Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II vemurafenib monotherapy in previously treated BRAF V600E-mutant hairy cell leukemia
2011-005487-13Phase 2Active
- Sponsor
- University of Perugia
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vemurafenib in hairy cell leukemia (HCL), sponsored by University of Perugia. Started May 2012; status: active.
02
Drugs
vemurafenib
03
Conditions
hairy cell leukemia (HCL)
Beyond the preview
Go deeper on 2011-005487-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005487-13.